BCN peptide

N3B30
Spain
Company Profile
  • Year Established: 1989
  • Total Number of Staff: 50-100
  • Main Competitive Advantages: Production Capacity,Contract Manufacturing (CRO,CMO),Reputation,Quality Service
  • Business Type: Manufacturer
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

BCN Peptides is completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. • Synthesis of API Peptides. We manufacture multi kilos batches using SPPS technology. Excellent GMP compliance: PMDA, US-FDA and EDQM Approved. BCN Peptides manufactures from milligrams up to commercial quantities. • Production of Peptides for Personalized Medicine. Manufacturing of Small quantities of GMP Peptides devoted for a single patient, including the aliquoting into vials.

Year Established: 1989

Total Number of Staff: 50-100

Main Competitive Advantages: Production Capacity,Contract Manufacturing (CRO,CMO),Reputation,Quality Service

Business Type: Manufacturer

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by